Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Research In Brief

This article was originally published in The Gray Sheet

Executive Summary

New approach for AF shows promise: Far-field antifibrillation - field electrodes delivering a short train of low-intensity electric pulses at the frequency of anti-tachycardia pacing - can terminate atrial fibrillation without the side effects of traditional high-voltage AF cardioversion, a canine study published in the August 11 issue of Circulation shows. The study was led by Flavio Fenton, Ph.D., Cornell University, and Stefan Luther, Ph.D., Planck Institute in Gottingen, Germany. In the study, the far-field approach terminated AF in 93% of attempts by generating wave emission sites within the tissue. "Further studies are needed to determine whether this marked reduction in energy can increase the effectiveness and safety for terminating atrial tachyarrhythmias clinically," the authors conclude
Advertisement

Related Content

FDA Contributes Funds To Industry Post-Stenting Antiplatelet Trial
FDA Contributes Funds To Industry Post-Stenting Antiplatelet Trial

Topics

Advertisement
UsernamePublicRestriction

Register

MT027799

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel